454 related articles for article (PubMed ID: 12197624)
1. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR
Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624
[TBL] [Abstract][Full Text] [Related]
2. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
3. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
4. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
5. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
Maddalozzo GF; Widrick JJ; Cardinal BJ; Winters-Stone KM; Hoffman MA; Snow CM
Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843
[TBL] [Abstract][Full Text] [Related]
6. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
[TBL] [Abstract][Full Text] [Related]
7. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
8. Impact of menopause on lipid and bone metabolism and effect of hormone replacement therapy.
Murano T; Izumi S; Kika G; Haque SF; Okuwaki S; Mori A; Suzuki T; Matsubayashi H; Ikeda M; Goya K; Makino T
Tokai J Exp Clin Med; 2003 Oct; 28(3):109-19. PubMed ID: 15055403
[TBL] [Abstract][Full Text] [Related]
9. Bone loss in oophorectomized Thai women.
Taechakraichana N; Limpaphayom K; Jaisamrarn U; Poshyachinda M
J Med Assoc Thai; 1997 Jun; 80(6):384-90. PubMed ID: 9240013
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):215-22. PubMed ID: 17576400
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of exogenous estrogen versus a estrogen-progesterone combination on auditory evoked potentials in menopausal women.
Khaliq F; Tandon OP; Goel N
Indian J Physiol Pharmacol; 2005; 49(3):345-52. PubMed ID: 16440855
[TBL] [Abstract][Full Text] [Related]
12. Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine.
Liu P; He FF; Bai WP; Yu Q; Shi W; Wu YY; He DJ; Xiao JH; Zheng Y; Liao QP
Chin Med J (Engl); 2004 Feb; 117(2):189-94. PubMed ID: 14975200
[TBL] [Abstract][Full Text] [Related]
13. The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva.
Yalçin F; Gurgan S; Gurgan T
J Contemp Dent Pract; 2005 May; 6(2):10-7. PubMed ID: 15915200
[TBL] [Abstract][Full Text] [Related]
14. [Mammography changes associated with hormone replacement therapy in post-menopausal patients].
Del Favero C; Rossini G; Tufarulo L; Ciancio ML; Sopransi M; Martegani A; Borghi C; Campi R; Fugazzola C
Radiol Med; 1997 Mar; 93(3):210-3. PubMed ID: 9221411
[TBL] [Abstract][Full Text] [Related]
15. Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial.
Ascott-Evans BH; Guanabens N; Kivinen S; Stuckey BG; Magaril CH; Vandormael K; Stych B; Melton ME
Arch Intern Med; 2003 Apr; 163(7):789-94. PubMed ID: 12695269
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
17. Menopause, hormone replacement and RR and QT modulation during sleep.
Lanfranchi PA; Gosselin N; Kara T; Jurak P; Somers VK; Denesle R; Petit D; Carrier J; Nadeau R; Montplaisir J
Sleep Med; 2005 Nov; 6(6):561-6. PubMed ID: 16198144
[TBL] [Abstract][Full Text] [Related]
18. Association between single nucleotide polymorphisms of estrogen receptor alpha gene and efficacy of HRT on bone mineral density in post-menopausal Japanese women.
Yahata T; Quan J; Tamura N; Nagata H; Kurabayashi T; Tanaka K
Hum Reprod; 2005 Jul; 20(7):1860-6. PubMed ID: 15831512
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
[TBL] [Abstract][Full Text] [Related]
20. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
